Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Puthenkalam, A. Panzenboeck, U. Schubert, J. Jakowitsch, K.T. Preissner, R. Voswinckel, W. Klepetko, I.M. Lang (Vienna, Austria; Giessen, Bad Nauheim, Germany). Angiogenesis in chronic thromboembolic pulmonary hypertension (CTEPH). Eur Respir J 2012; 40: Suppl. 56, 3892

Member's Comments

No comment yet.

Related content which might interest you: Chronic thromboembolic pulmonary hypertension (CTEPH) and beyond Source: Annual Congress 2011 - Ceremony for Pulmonary Arterial Hypertension Award (supported by Actelion) followed by Pulmonary Hypertension in the Clinic Grand Round - an interactive session Year: 2011 Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005 Chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Update on venous thromboembolism Year: 2007 Chronic thromboembolic pulmonary hypertension (CTEPH) and coagulation defects: Before and after treatment Source: International Congress 2017 – PAH and CTEPH Year: 2017 ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Prevalence of relapses and chronic thromboembolic pulmonary hypertension (CTEPH) in patients with pulmonary embolism (PE) Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Thrombophilic risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) in Korea Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Platelets and chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Russian Programme 2017 Year: 2017 Chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases Year: 2018 Chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (1) 1801915; 10.1183/13993003.01915-2018 Year: 2019 Chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension Year: 2015 Endothelial dysfunction in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007